Oral third-generation cephalosporins in the treatment of community-acquired urinary tract infections | CMAC

Oral third-generation cephalosporins in the treatment of community-acquired urinary tract infections

Clinical Microbiology and Antimicrobial Chemotherapy. 2019; 21(3):225-228

​ Kozlov R.S., Palagin I.S., Golub A.V.
10.36488/cmac.2019.3.225-228
urinary tract infections acute cystitis acute pyelonephritis cefixime cephalosporins
Section
Antimicrobials
Type
Review
Publication
Clinical Microbiology and Antimicrobial Chemotherapy. 2019; 21(3):225-228

Abstract

Cephalosporins are one of the most commonly used antimicrobials for the treatment of variety of bacterial infections. Prudent use of the third-generation cephalosporins is important for the control of spread of cephalosporin-resistant Gram-negative bacteria, especially ESBL-producing Enterobacterales strains. One of the therapeutic areas where the balance between the clinical efficacy and antimicrobial resistance is of critical importance for cephalosporins is urinary tract infections. Current review summarizes existing data on the use of oral third-generation cephalosporins in the treatment of urinary tract infections with a special emphasis to the microbiological data.

Roman S. Kozlov

Institute of Antimicrobial Chemotherapy, Smolensk, Russia

Ivan S. Palagin

Institute of Antimicrobial Chemotherapy, Smolensk, Russia

Alexey V. Golub

Institute of Antimicrobial Chemotherapy, Smolensk, Russia

  • 1. Parker S., Mitchell M., Child J. Cephem antibiotics: wise use today preserves cure for tomorrow. Pediatr Review. 2013;34(11):510-523. DOI: 10.1542/pir.34-11-510
  • 2. Antibacterial therapy and prevention of infections of the kidneys, urinary tract and male genital organs. Federal clinical guidelines. M: «PRIMA-print», 2017. 72 р. Russian.
  • 3. Kozlov R.S., Golub A.V. Antimicrobial stewardship as a renascence of the «golden age» of antibiotics. Klinicheskaja mikrobiologija i antimikrobnaja himioterapija. 2011;13(4):322-334. Russian.
  • 4. Palagin I.S., Sukhorukova M.V., Dekhnich A.V., Edelstein M.V., Shevelev A.N., Grinyov A.V., et al. Current state of antibiotic resistance of pathogens causing community-acquired urinary tract infections in Russia: «DARMIS» study (2010-2011). Klinicheskaja mikrobiologija i antimikrobnaja himioterapija. 2012;14(4):280-302. Russian.
  • 5. Palagin I.S., Sukhorukova M.V., Dekhnich A.V., Edelstein M.V., Perepanova T.S., Kozlov R.S. et al. Antimicrobial resistance of pathogens causing community-acquired urinary tract infections in Russia: results of the multicenter study «DARMIS-2018». Klinicheskaja mikrobiologija i antimikrobnaja himioterapija. 2019;21(2):134-146. Russian. DOI: 10.36488/cmac.2019.2.134-146.
  • 6. Kresken M., Körber-Irrgang B., Biedenbach D.J., Batista N., Besard V., Canton R., et al. Comparative in vitro activity of oral antimicrobial agents against Enterobacteriaceae from patients with community-acquired urinary tract infections in three European countries. Clin Microbiol Infect. 2016;22(1):63.e1-5. DOI: 10.1016/j.cmi.2015.08.019
  • 7. Martin D., Fougnot S., Grobost F., Thibaut-Jovelin S., Ballereau F., Gueudet T., et al. Prevalence of extended-spectrum betalactamase producing Escherichia coli in community-onset urinary tract infections in France in 2013. J Infect. 2016;72(2):201-206. DOI: 10.1016/j.jinf.2015.11.009
  • 8. Pistiki A., Tsaganos T., Galani I., Giamarellos-Bourboulis E.J. In vitro activity of oral cephalosporins (cefprozil and cefixime) against ciprofloxacin-resistant Enterobacteriaceae from communityacquired urinary-tract infections. Infect Dis Ther. 2015;4(4):425-432. DOI: 10.1007/s40121-015-0089-3
  • 9. Malmartel A., Ghasarossian C. Epidemiology of urinary tract infections, bacterial species and resistance in primary care in France. Eur J Microbiol Infect Dis. 2016;35(3):447-451. DOI: 10.1007/s10096-015-2560-1
  • 10. Etienne M., Van Elslande H., Choplin-Renald J., Pestel-Caron M., Caron F. Antibiotic resistance in adult female patients hospitalized for acute pyelonephritis: rates and predicting factors. Med Mal Infect. 2014;44(5):217-222. DOI: 10.1016/j.medmal.2014.03.003
  • 11. Kozlov R.S., Golub A.V. Choice of antimicrobial agents in uncomplicated urinary tract infections: how to make decision worthy of Solomon? Klinicheskaja mikrobiologija i antimikrobnaja himioterapija. 2014;16(1):18-25. Russian.
  • 12. Cohen R., Raymond J., Faye A., Gillet Y., Grimprel E. Management of urinary tract infections in children. Recommendations of the pediatric infectious diseases group of the French pediatrics society and French-language infectious diseases society. Arch Pediatr. 2015;22(6):665-671. DOI: 10.1016/j.arcped.2015.03.016
  • 13. Robinson J.L., Finlay J.C., Lung M.E., Bortolussi R. Urinary tract infections in infants and children: diagnosis and management. Paediatr Child Health. 2014;19(6):315-319. DOI: 10.1093/pch/19.6.315
  • 14. Sanchez M., Collvinent B., Miro O., Horcajada J.P., Moreno A., Marco F., et al. Short-term effectiveness of ceftriaxone single dose in the initial treatment of acute uncomplicated pyelonephritis in women. A randomised controlled trial. Emerg Med J. 2002;19(1):19-22. DOI: 10.1136/emj.19.1.19
  • 15. Moustafa F., Nguyen G., Mathevon T., Baud O., SaintDenis J., Dublanchet N., et al. Evaluation of the efficacy and tolerance of a short 7 day third-generation cephalosporin treatment in the management of acute pyelonephritis in young women in the emergency department. J Antimicrob Chemother. 2016;71(6):1660-1664. DOI: 10.1093/jac/dkw021
  • 16. Gupta K., Hooton T.M., Naber K.G., Wullt B., Colgan R., Miller L.G., et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the IDSA and the ESCMID. Clin Infect Dis. 2011;52(5):e103-120. DOI: 10.1093/cid/ciq257
  • 17. Karpov O.I. Pyelonephritis: are the 3rd generation cephalosporins still relevant? Farmateka. 2005;6:65-69. Russian.
  • 18. Bloomfield P., Hodson E.M., Craig J.C. Antibiotics for acute pyelonephritis in children. Cochrane Database Syst Rev. 2003;3:CD003772. DOI: 10.1002/14651858.CD003772
  • 19. Hodson E.M., Willis N.S., Craig J.C. Antibiotic for acute pyelonephritis in children. Cochrane Database Syst Rev. 2007;4:CD003772. DOI: 10.1002/14651858.CD003772.pub3
  • 20. Bocquet N., Sergent Alaoui A., Jais J.P., Gajdos V., Guigonis V., Lacour B., et al. Randomized trial of oral versus sequential IV/oral antibiotic for acute pyelonephritis in children. Pediatrics. 2012;129(2):269-275. DOI: 10.1542/peds.2011-0814
  • 21. Bonkat G., Bartoletti R.R., Bruyere F., Cai T., Geerlings B., Koves B., et al. Urological infections. Available at: https://uroweb.org/guideline/urological-infections/. Accessed September 01, 2019.
  • 22. Zyryanov S.K. Comparative evaluation of dissolution kinetics of cefixime preparations. Farmateka. 2016;10:1-4. Russian.
  • 23. Auchenthaler R. Pharmakokinetics and pharmakodynamics of oral beta-lactam antibiotics as a two dimensional approach to their efficacy. J Antimicrob Chemother. 2002;50(Suppl):13-17. DOI: 10.1093/jac/dkf803
  • 24. Berthe-Aucejo A., Girard D., Lorrot M., Bellettre X., Faye A., Mercier J.C., et al. Evaluation of frequency of paediatric oral liquid medication dosing errors by caregivers: amoxicillin and josamycin. Arch Dis Child. 2016;101(4):359-364. DOI: 10.1136/archdischild-2015-309426
  • 25. Dispersible Tablets. Available at: www.unicef.org/supply/index_53571.html. Accessed September 01, 2019.
  • 26. Vlasova I. Patients prefer a single dose of antibiotics. Farmacevticheskij vestnik. 2007. Available at: www.pharmvestnik.ru/publs/lenta/v-rossii/4036.html#.VF-TEmdih0s. Russian.
  • 27. Claxton A.J., Cramer J., Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther. 2001;23(8):1296-1310. DOI: 10.1016/s0149-2918(01)80109-0
Views
0 Abstract
0 PDF
0 Crossref citations
Shared